|
|
||||||||


*
Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037;
Novo Nordisk A/S, Bagsvaerd, Denmark; and
Pacific Northwest Research Institute, University of Washington, Department of Medicine, Seattle, WA 98195
We evaluated the role of the humoral arm of the immune
response in causing or contributing to virus-induced diabetes.
Transgenic mice expressing the nucleoprotein (NP) or glycoprotein (GP)
of the lymphocytic choriomeningitis virus (LCMV) under control of the
rat insulin promoter (RIP) in pancreatic
cells (RIP-LCMV) and
RIP-LCMV mice with genetic dysfunction of B cells (RIP-LCMV x
µMT/µMT) were compared
for development of diabetes after challenge with LCMV. After
inoculation with LCMV, B and T lymphocytes and macrophages infiltrated
into pancreatic islets in RIP-LCMV mice, and over 50% of these mice
generated Abs against host insulin or glutamate decarboxylase. However,
neither B cells nor the autoantibodies played a direct role in the
initiation, kinetics, or severity of the virus-induced diabetes as
judged by comparing disease in RIP-LCMV mice to littermates whose
functional B cells were genetically eliminated. Furthermore, the
quality and quantity of T lymphocyte and macrophage infiltration was
similar in the B cell-deficient and non-B cell-deficient RIP-LCMV mice.
Although the development of autoantibodies to islet Ags had no direct
influence on the pathogenesis of insulin-dependent (type 1) diabetes
mellitus, it served as a prediabetes marker, as such autoantibodies
were often elevated before the onset of disease. Hence, the RIP-LCMV
model is not only useful for understanding the pathogenetic mechanisms
of how islets are destroyed and spared but also for evaluating
therapeutic strategies before onset of clinical
diabetes.
This article has been cited by other articles:
![]() |
A. Rhode, M. E. Pauza, A. M. Barral, E. Rodrigo, M. B. A. Oldstone, M. G. von Herrath, and U. Christen Islet-Specific Expression of CXCL10 Causes Spontaneous Islet Infiltration and Accelerates Diabetes Development J. Immunol., September 15, 2005; 175(6): 3516 - 3524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Juedes, E. Rodrigo, L. Togher, L. H. Glimcher, and M. G. von Herrath T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes J. Exp. Med., April 19, 2004; 199(8): 1153 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Del Pozzo, D. Mascolo, A. Prisco, P. Barba, A. Anzisi, and J. Guardiola Lack of patent liver autoimmunity after breakage of tolerance in a mouse model Int. Immunol., October 1, 2003; 15(10): 1173 - 1181. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |